TrialBritish journal of haematology2021

Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study.

Jun Ho Jang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.